Intraprostatic Botulinum Toxin Type A injection in patients with benign prostatic enlargement: duration of the effect of a single treatment

BACKGROUND: Botulinum Toxin Type-A (BoNT/A) intraprostatic injection can induce prostatic involution and improve LUTS and urinary flow in patients with Benign Prostatic Enlargement (BPE). However, the duration of these effects is unknown. The objective of this work was to determine the duration of p...

Descripción completa

Detalles Bibliográficos
Autores principales: Silva, João, Pinto, Rui, Carvalho, Tiago, Botelho, Francisco, Silva, Pedro, Oliveira, Rui, Silva, Carlos, Cruz, Francisco, Dinis, Paulo
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2734751/
https://www.ncbi.nlm.nih.gov/pubmed/19682392
http://dx.doi.org/10.1186/1471-2490-9-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2734751/
https://www.ncbi.nlm.nih.gov/pubmed/19682392
http://dx.doi.org/10.1186/1471-2490-9-9

Ejemplares similares